Description
Provided is an aglycosylated humanized anti-Bb (AAfBb) antibody includes a modification at a conserved N-linked site in the CH2 domains of an Fc portion of the antibody. AAfBb antibody is a specific inhibitor of the AP and does not inhibit or activate the classical pathway. AAfBb antibody binds to Bb so as to prevent cleavage of Factor B to produce Bb when present in the complex PC3bB.
Target
CFB
Target Alias Names
Complement Factor B, B-Factor, Properdin, Properdin Factor B, C3/C5 Convertase, EC 3.4.21.47, PBF2, BFD, GBG, BF, Glycine-Rich Beta-Glycoprotein, Glycine-Rich Beta Glycoprotein
Isotype/Mimetic
Humanized IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression

